On July 14, 2017, the Board of Directors of Capstone Therapeutics Corp. voted to expand the size of the Board from three to five members and appointed Matthew E. Lipman to fill the vacancy in Class II of the Board and Michael M. Toporek to fill the vacancy in Class III of the Board, to serve in such capacities until the company’s 2017 and 2018 Annual Meeting of Stockholders, respectively, or until their successors are duly elected and qualified. The Board has determined that Lipman will serve on the Audit Committee of the Board and Toporek will serve on the Compensation Committee of the Board. Michael M. Toporek has served as a director of Mechanical Technology, Incorporated since October 21, 2016.